Comments to FDA: External Analgesic Drug Products for OTC Human Use Share page: Docket Number: 78N-0301 In this submission the task group provides updated data on the safety of counterirritants administered via patched or other novel dosage forms. Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Applauds White House Executive Order Prioritizing Lower Drug Costs and Access to Self-Care Apr 17, 2025 Press Releases and Statements CHPA Responds to Section 232 Investigation on Pharmaceuticals Apr 15, 2025 Press Releases and Statements CHPA Commends Lawmakers for Urging FDA to Protect the Rx-OTC-Switch Pathway Apr 11, 2025